drugset / Trial / NCT06122012

To Evaluate the Efficacy and Safety of HSK16149 With L-carnitine in Diabetic Peripheral Neuralgia Patients in China

NCT06122012

RandomizedParallel-groupOpen-labelTreatment

Summary

Observe the effects of HSK16149 capsule combined with acetyl-L-carnitine hydrochloride tablets and lipoic acid combined with acetyl-L-carnitine hydrochloride tablets Efficacy and safety in diabetic peripheral neuralgia patients in China

Timeline

Start
2023-05-01
Primary completion
2024-04-30
Completion
2024-05

Drugs

EvaluationDrugModalityDoseRoute
Subject HSK16149 Unknown 20 mg Oral
Subject alpha-lipoic acid Small molecule 0.6 g Oral
Background L-carnitine Other / unclassified 0.5 g Oral